Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 11:363-71.. 2011.
Imputing viral subtype in time to virological failure analyses. International Workshop on HIV Observational Databases (IWHOD) 2015.. 2015.
No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.. 2016.
No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.. 2016.
No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. International HIV Drug Resistance Workshop 2016.. 2016.
Bayesian Phylogeography of HIV among MSM in the UK Indicates a Few Source Areas of Widespread Infection. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
Clustering and Geography: analysis of HIV transmission among UK MSM. 16th International HIV Dynamics & Evolution Meeting, April 2009.. 2009.
Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.. J Infect Dis. 217(10):1522-1529.. 2018.
Phylodynamic analysis to guide allocation of Pre-Exposure Prophylaxis in the United Kingdom. 24th International HIV Dynamics and Evolution.. 2017.
The increasing genetic diversity of HIV-1 in the UK, 2002-2010. AIDS. 28:773-80.. 2014.
Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008 to 2015. BHIVA Spring.. 2018.
Trends in transmitted drug resistance to HIV-1 in the UK since 2010. British HIV Association Conference (BHIVA) 2015.. 2015.
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis.. 2016.
Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation. HIV Med.. 2020.
Novel methodology to evaluate associations between baseline characteristics, CD4 response and viral failure on first-line ART for HIV. 22nd International Workshop on HIV and Hepatitis Observational Databases.. 2018.